association

Full identifier: http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#association

Assigned to 1 class:

Minted in Nanopublication

 RAm5e2akNd comment approve/disapprove edit as derived nanopublication create new with same template

This is a local identifier minted within the nanopublication. http://purl.org/np/RAm5e2akNd...#association This association http://www.w3.org/2000/01/rdf-schema#label has label (this is a literal) "carefully consider the potential benefits and risks of celebrex and other treatment options before deciding to use celebrex use the lowest effective dose for the shortest duration consistent with individual patient treatment goals see warnings and precautions 5 celebrex is a nonsteroidal anti inflammatory drug indicated for osteoarthritis oa 1 1 rheumatoid arthritis ra 1 2 juvenile rheumatoid arthritis jra in patients 2 years and older 1 3 ankylosing spondylitis as 1 4 acute pain ap 1 5 primary dysmenorrhea pd 1 6 familial adenomatous polyposis fap adjunct to usual care 1 7 celebrex is indicated for relief of the signs and symptoms of oa see clinical studies 14 1 celebrex is indicated for relief of the signs and symptoms of ra see clinical studies 14 2 celebrex is indicated for relief of the signs and symptoms of jra in patients 2 years and older see clinical studies 14 3 celebrex is indicated for the relief of signs and symptoms of as see clinical studies 14 4 celebrex is indicated for the management of ap in adults see clinical studies 14 5 celebrex is indicated for the treatment of pd see clinical studies 14 5 celebrex is indicated to reduce the number of adenomatous colorectal polyps in fap as an adjunct to usual care e g endoscopic surveillance surgery it is not known whether there is a clinical benefit from a reduction in the number of colorectal polyps in fap patients it is also not known whether the effects of celebrex treatment will persist after celebrex is discontinued the efficacy and safety of celebrex treatment in patients with fap beyond six months have not been studied see warnings and precautions 5 15 clinical studies 14 6" .
This is the identifier for this whole nanopublication. http://purl.org/np/RAm5e2akNd... This nanopublication date and time when the nanopublication was created http://purl.org/dc/terms/created was created on (this is a literal) "2021-06-29T08:54:30.583+02:00" .
This is the identifier for this whole nanopublication. http://purl.org/np/RAm5e2akNd... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RAManV5GZI... RAManV5GZI .
This is the identifier for this whole nanopublication. http://purl.org/np/RAm5e2akNd... This nanopublication links to the provenance template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate was created from the provenance template http://purl.org/np/RANwQa4ICW... RANwQa4ICW .
This is the identifier for this whole nanopublication. http://purl.org/np/RAm5e2akNd... This nanopublication links to the publication info template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate was created from the publication info template http://purl.org/np/RAA2MfqdBC... RAA2MfqdBC .
This is a local identifier minted within the nanopublication. http://purl.org/np/RAm5e2akNd...#sig sig http://purl.org/nanopub/x/hasSignatureTarget has as target This is the identifier for this whole nanopublication. http://purl.org/np/RAm5e2akNd... this nanopublication .
This is a local identifier minted within the nanopublication. http://purl.org/np/RAm5e2akNd...#sig sig http://purl.org/nanopub/x/hasAlgorithm has the algorithm (this is a literal) "RSA" .

Leoni Bücken, 29 Jun 2021, 06:54:30 UTC

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-29T06:54:30.583Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
carefully consider the potential benefits and risks of celebrex and other treatment options before deciding to use celebrex use the lowest effective dose for the shortest duration consistent with individual patient treatment goals see warnings and precautions 5 celebrex is a nonsteroidal anti inflammatory drug indicated for osteoarthritis oa 1 1 rheumatoid arthritis ra 1 2 juvenile rheumatoid arthritis jra in patients 2 years and older 1 3 ankylosing spondylitis as 1 4 acute pain ap 1 5 primary dysmenorrhea pd 1 6 familial adenomatous polyposis fap adjunct to usual care 1 7 celebrex is indicated for relief of the signs and symptoms of oa see clinical studies 14 1 celebrex is indicated for relief of the signs and symptoms of ra see clinical studies 14 2 celebrex is indicated for relief of the signs and symptoms of jra in patients 2 years and older see clinical studies 14 3 celebrex is indicated for the relief of signs and symptoms of as see clinical studies 14 4 celebrex is indicated for the management of ap in adults see clinical studies 14 5 celebrex is indicated for the treatment of pd see clinical studies 14 5 celebrex is indicated to reduce the number of adenomatous colorectal polyps in fap as an adjunct to usual care e g endoscopic surveillance surgery it is not known whether there is a clinical benefit from a reduction in the number of colorectal polyps in fap patients it is also not known whether the effects of celebrex treatment will persist after celebrex is discontinued the efficacy and safety of celebrex treatment in patients with fap beyond six months have not been studied see warnings and precautions 5 15 clinical studies 14 6
Leoni Bücken
2021-06-29T06:54:30.583Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-29T06:54:30.583Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-29T06:54:30.583Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-29T06:54:30.583Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-29T06:54:30.583Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-29T06:54:30.583Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-06-29T06:54:30.583Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)